Delivery Order SPE2DB22D1103-SPE2DB25FTQJ2
Award Date
6/24/25
Potential Completion Date
7/16/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,119.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide INQOVI 35 MG-100 MG tablets. The contract has an ultimate completion date of June 20, 2025 and is not set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for supplying a wide...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $5,119.36 firm fixed-price delivery order contract is for the supply of INQOVI 35 MG-100 MG tablets. The contract has an ultimate completion date of April 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a ceiling value of $5,119.36 and a period of performance through July 9, 2025. The contract is not designated as a set-aside and was awarded on June 16, 2025. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 firm fixed-price contract is for the delivery of INQOVI 35 MG-100 MG TABLET UU 5S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen is the prime contractor, with no major subcontractors mentioned. The award is not associated with a specific set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INQOVI 35 MG-100 MG tablets. The $4,830.47 contract has a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
This is a delivery order awarded to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, specifically the drug INQOVI 35 MG-100 MG TABLET. The contract has a firm-fixed price of $14,491.41 and a completion date of September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of INQOVI 35 MG-100 MG tablets. The $5,119.36 firm fixed-price contract has a period of performance through March 7, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,119.36, is for the delivery of the prescription medication Inqovi 35 mg-100 mg tablets. The contract has an ultimate completion date of May 20, 2025. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product INQOVI 35 MG-100 MG TABLET, with a ceiling value of $5,119.36 and a period of performance through July 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $5,119.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...